These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 480619)

  • 1. Is calcitriol [1,25(OH)2D3] harmful to renal function?
    Massry SG; Goldstein DA
    JAMA; 1979 Oct; 242(17):1875-6. PubMed ID: 480619
    [No Abstract]   [Full Text] [Related]  

  • 2. Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol.
    Christiansen C; Rødbro P; Christensen MS; Hartnack B; Transbøl I
    Lancet; 1978 Sep; 2(8092 Pt 1):700-3. PubMed ID: 80633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.
    Teitelbaum SL
    Ann Intern Med; 1981 Mar; 94(3):404-5. PubMed ID: 6894359
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure.
    Brickman AS; Coburn JW; Norman AW; Massry SG
    Am J Med; 1974 Jul; 57(1):28-33. PubMed ID: 4600292
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL; Felsenfeld AJ; Llach F
    Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.
    Kanis JA; Russell RG
    Br Med J; 1977 Jan; 1(6053):78-81. PubMed ID: 832019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirements of vitamin D metabolites in patients with renal disease.
    Massry SG
    Am J Clin Nutr; 1980 Jul; 33(7):1530-5. PubMed ID: 6893103
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intestinal absorption of Ca47 in chronic renal insufficiency before and after treatment with 1,25 dihydroxycholecalciferol].
    Vattimo A
    Minerva Med; 1979 Dec; 70(54):3705-7. PubMed ID: 523001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitriol in disorders of bone and calcium metabolism.
    Riggs BL
    Clin Ther; 1980; 3(1):33-9. PubMed ID: 6893296
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.
    Muirhead N; Catto GR; Edward N; Fraser RA; O'Riordan JL; Papapoulos SE; Adami S
    Proc Eur Dial Transplant Assoc; 1980; 17():543-7. PubMed ID: 6972529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The duodenal mucosa in patients with renal failure: response to 1,25(OH)2D3.
    Goldstein DA; Horowitz RE; Petit S; Haldimann B; Massry SG
    Kidney Int; 1981 Feb; 19(2):324-31. PubMed ID: 6894470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin-D analogues and renal function.
    Christiansen C; Christensen MS; Hartnack B; Melsen F; Transbøl I; Rødbro P
    Lancet; 1979 Jan; 1(8106):50-1. PubMed ID: 83502
    [No Abstract]   [Full Text] [Related]  

  • 13. Impairment of renal function in patients on 1alpha-hydroxycholecalciferol.
    Winterborn MH; Mace PJ; Heath DA; White RH
    Lancet; 1978 Jul; 2(8081):150-1. PubMed ID: 78344
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum 1,25-dihydroxycholecalciferol in anephric, haemodialyzed and kidney-transplanted patients. Effect of vitamin D3 supplement.
    Lund B; Clausen E; Friedberg M; Lund B; Moszkowicz M; Nielsen SP; Sørensen OH
    Nephron; 1980; 25(1):30-3. PubMed ID: 6243405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcemia during long-term treatment with 1,25-dihydroxyvitamin D3 in hypoparathyroidism.
    Bell NH; Epstein S; Stern PH
    N Engl J Med; 1979 Nov; 301(21):1183-4. PubMed ID: 492291
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs in current use: calcitriol.
    Aust Nurses J; 1980 Feb; 9(7):27-8. PubMed ID: 6900485
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term effects of 1,25(OH)2D3 on clinical and biochemical derangements of divalent ions in dialysis patients.
    Goldstein DA; Malluche HH; Massry SG
    Contrib Nephrol; 1980; 18():42-54. PubMed ID: 7353379
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypercalcemia and increases in serum hormone value during prolonged administration of 1alpha,25-dihydroxyvitamin D.
    Bell NH; Stern PH
    N Engl J Med; 1978 Jun; 298(22):1241-3. PubMed ID: 651964
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcitriol.
    Med Lett Drugs Ther; 1979 Jun; 21(12):50-1. PubMed ID: 449839
    [No Abstract]   [Full Text] [Related]  

  • 20. 1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.
    Berl T; Berns AS; Hufer WE; Hammill K; Alfrey AC; Arnaud CD; Schrier RW
    Ann Intern Med; 1978 Jun; 88(6):774-80. PubMed ID: 208439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.